Pfizer is expected to get full approval for its COVID-19 vaccine by Labor Day, according to The New York Times.
The Food and Drug Administration has not verified the timeline.
Pfizer is expected to get full approval for its COVID-19 vaccine by Labor Day, according to The New York Times.
The Food and Drug Administration has not verified the timeline.